Marker Therapeutics, Inc. Stock Analysis & AI Score
Marker Therapeutics, Inc. (MRKR) has an ST Score of 38.5 (C), driven by its Financial Strength (B) and held back by its Profitability (D+). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Marker Therapeutics, Inc. (MRKR) has an ST Score of 38.5 (C), driven by its Financial Strength (B) and held back by its Profitability (D+). Analysts rate it Buy.
- Strongest
- Financial StrengthB
- Weakest
- ProfitabilityD+
All factor grades
- Financial StrengthB
- ValuationC+
- MomentumC
- GrowthC-
- ProfitabilityD+
- Piotroski2/9
Contact
MRKR stock: frequently asked questions
What is MRKR's ST Score?
Marker Therapeutics, Inc. (MRKR) has an ST Score of 38.5 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MRKR a buy, hold, or sell?
Analysts rate MRKR a Buy. Our ST Score grades it C (38.5/100). The ST Score is a data-driven signal, not a recommendation.
What are MRKR's factor grades?
Valuation C+, Profitability D+, Financial Strength B, Momentum C, Growth C-.
What is MRKR's valuation grade?
Marker Therapeutics, Inc. (MRKR) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MRKR's growth grade?
Marker Therapeutics, Inc. (MRKR) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MRKR's profitability grade?
Marker Therapeutics, Inc. (MRKR) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MRKR's financial strength grade?
Marker Therapeutics, Inc. (MRKR) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is MRKR's Piotroski score?
Marker Therapeutics, Inc. (MRKR) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.